ATP5F1E and breast carcinoma: To address this hypothesis, we treated cells with the mitochondrial ATPase inhibitor oligomycin, and found that 100 nM oligomycin treatment decreased ATP levels in breast cancer cells (Figures 2A,B, left panel).